Phase II Study in Patients With Metastatic Colorectal Carcinoma Previously Treated With Oxaliplatin (OXAL) or a Combination of Irinotecan (CPT-11) and OXAL
Latest Information Update: 03 Nov 2021
Price :
$35 *
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2005 New trial record.